One of Metsera's drug candidates, MET-233i, can be taken less frequently than the Novo Nordisk and Lilly drugs, and has ...

As global markets navigate a period of heightened volatility, with U.S. stocks snapping a three-week winning streak amid concerns over AI spending and the longest federal government shutdown on record ...

Real-world data across more than 1 million patients published in Heart Rhythm show that 24–48-hour monitoring can miss actionable arrhythmias and highlights the value of iRhythm’s Zio® long-term ...